Michael D. Lairmore, DVM, PhD, dean of the UC Davis School of Veterinary Medicine, oversees all School of Veterinary Medicine activities, personnel, facilities and funding resources. He presides over the William R. Pritchard Veterinary Medical Teaching Hospital, the California Animal Health and Food Safety Laboratory System, the Veterinary Medicine Teaching and Research Center in Tulare, Veterinary Medicine Extension and other centers of excellence.
Lairmore came to the school from The Ohio State University. He served as a professor and associate dean for research and graduate studies at the College of Veterinary Medicine, where he led a successful sponsored research and commercialization program. He also served as associate director of the university's Comprehensive Cancer Center. While Chair for the Department of Veterinary Biosciences, he received unanimous praise for leading his department to new heights in research funding and scholarly achievement.
He is committed to finding new ways for the school and its faculty to contribute to the health of the animals and people while being good stewards of the environment and the economy of California. His goals include building mission-focused programs that will continue to provide outstanding education for society-ready veterinarians and that will produce innovative research findings to address important problems ranging from clinical veterinary medicine to public health.
Lairmore earned his Doctor of Veterinary Medicine degree from the University of Missouri at Columbia. He is board certified in veterinary anatomic pathology as well as virology and immunology, and he holds a doctorate in experimental pathology. He is one of the few veterinarians elected as a member of the Institute of Medicine, the health arm of the National Academy of Sciences. He is also a fellow in the American Academy of Microbiology and the American Association for the Advancement of Sciences.
Lairmore is a scientist who bridges multiple disciplines to address basic questions related to viral causes of cancer. His research has provided significant breakthroughs in the biology of the human retroviruses and the understanding of viral-associated carcinogenesis. He developed one of the first models of AIDS-associated pediatric pneumonia. After developing a reference laboratory at the Centers for Disease Control and Prevention for Human T cell leukemia/lymphotropic virus type 1 (HTLV-1), he discovered the first HTLV-2 infection in native Indian populations in Central America, subsequently recognized as an endemic infection among American Indian populations throughout North and South America. Lairmore has authored or co-authored more than 175 scientific publications.